Charles River Laboratories International Inc (NYSE:CRL)
$ 232.56 -0.26 (-0.11%) Market Cap: 11.98 Bil Enterprise Value: 14.74 Bil PE Ratio: 27.30 PB Ratio: 3.29 GF Score: 95/100

Charles River Laboratories International Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 13, 2021 / 02:15PM GMT
Release Date Price: $431.22 (-2.22%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

Hey, everyone. Good morning. Thanks for joining us at the Morgan Stanley Healthcare Conference. I'm Tejas Savant, and I cover the life science tools and diagnostics sector here at Morgan Stanley. I'm delighted to have Charles River join us this morning. And representing the company is Jim Foster, Chairman, President and CEO. So welcome, Jim.

James C. Foster
Charles River Laboratories International, Inc. - Chairman, CEO & President

Nice to be here.

Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

Before we get into the Q&A, I just wanted to quickly rattle off my safe harbor. Please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, please do reach out to your sales rep.

Questions & Answers

Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

So with that, thanks for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot